Desmond Tutu TB Centre
Paediatrics and Child Health
Dr Isabelle Dewandel, Paediatrician and research clinician - MD, BSc (Biomedical Sciences): Isabelle Dewandel is a paediatrician with a keen interest in paediatric infectious diseases, mainly tuberculosis/HIV and respiratory infections. She joined the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa in 2020 to be part of the paediatric platform with main focus on paediatric tuberculosis, lung health and COVID-19 research within a high TB/HIV burden setting.

Presenter of 1 Presentation

LONG-TERM IMPACT OF SARS-COV-2 INFECTION IN CHILDREN PRESENTING TO TYGERBERG HOSPITAL DURING THE COVID-19 PANDEMIC IN CAPE TOWN, SOUTH AFRICA

Session Type
Oral Presentations
Date
Wed, 23.02.2022
Session Time
09:45 AM - 10:45 AM
Room
Sala E
Lecture Time
10:25 AM - 10:35 AM

Abstract

Background

Little is known about long-term impact of COVID-19 in children in low- middle income countries.

Aims

To determine long-term consequences in SARS-CoV-2 PCR positive children versus SARS-CoV-2 negative children.

Methods

In this prospective observational cohort study, children aged 0-13 years were recruited from Tygerberg Hospital in Cape Town, South Africa between June 2020 and September 2021, presenting with either 1) an acute respiratory illness, 2) confirmed COVID-19 PCR or 3) a COVID-19 contact. Clinical data and serum samples were obtained at baseline and children were followed 3 months and 1 year later.

Results

A total of 100 children were enrolled, median age 7 months (interquartile range 2.0-31.5 months), 61 (61%) male; 2 (2%) HIV-infected and 25 (25 %) HIV-exposed. A total of 44 (44%) children tested COVID-19 positive on PCR. Underlying comorbidities were seen more frequently in COVID PCR positive cases (40.9%) compared to COVID negative cases (33.9%). One year after initial enrolment 12/41 (29.3%) children had persistent or recurrent symptoms and were more likely to be COVID-19 PCR positive (p=0.01). A total of 40/100 (40%) children were readmitted, with no significant difference between children with or without previous COVID-19 diagnosis. At baseline SARS-CoV-2 antibodies were found in 43/85 (50.6%) and after 1 year 31/39 (79.5%) were SARS-CoV-2 antibody positive.

wspid_figure1.jpg

Conclusions

Children who had confirmed SARS-CoV-2 infection were more likely to have symptoms 1 year later. The vast majority of this cohort had evidence of SARS-CoV-2 infection by 1 year after enrolment.

Hide